Publication Date
| In 2026 | 0 |
| Since 2025 | 1 |
Descriptor
| Autism Spectrum Disorders | 1 |
| Comorbidity | 1 |
| Depression (Psychology) | 1 |
| Drug Therapy | 1 |
| Intervention | 1 |
| Patients | 1 |
| Program Effectiveness | 1 |
| Program Termination | 1 |
| Symptoms (Individual… | 1 |
Source
| Journal of Autism and… | 1 |
Author
| Cara Fosdick | 1 |
| Christopher J. McDougle | 1 |
| Craig A. Erickson | 1 |
| Elizabeth Smith | 1 |
| Ernest V. Pedapati | 1 |
| Katherine Harris | 1 |
| Kelli C. Dominick | 1 |
| Lauren Schmitt | 1 |
| Martine Lamy | 1 |
| Meredith Will | 1 |
| Rebecca C. Shaffer | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkRiley A. Argonis; Ernest V. Pedapati; Kelli C. Dominick; Katherine Harris; Martine Lamy; Cara Fosdick; Lauren Schmitt; Rebecca C. Shaffer; Elizabeth Smith; Meredith Will; Christopher J. McDougle; Craig A. Erickson – Journal of Autism and Developmental Disorders, 2025
Introduction: Depression impacts many individuals with autism spectrum disorder (ASD), carrying increased risk of functional impairment, hospitalization, and suicide. Prescribing medication to target depression in patients with ASD occurs despite limited available systematic data describing medication management of depression in this population.…
Descriptors: Drug Therapy, Depression (Psychology), Autism Spectrum Disorders, Patients
